Anyone experiencing persistent abdominal pain, blood in the stool, unexplained weight loss, severe constipation, or ongoing diarrhea should seek medical evaluation rather than relying on a supplement
10.7759/cureus.43697 81 TaalM
Current Status of Compounding of Semaglutide: With respect to the current status of compounding of semaglutide, FDA noted that it wished to avoid unnecessary disruption to patient treatment, and outlined the current enforcement policy moving forward: [T]he agency does not intend to take action against compounders for violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act) arising from conditions that depend on semaglutide injection products inclusion on FDAs drug shortage list: For a state-licensed pharmacy under section 503A of the FD&C Act compounding, distributing or dispensing semaglutide injections within 60 calendar days from todays announcement, until
Always default to the shorter end of that range and consult the specific compound's documentation, since longer, more complex peptide chains generally degrade faster than short, stable sequences
February 1, 2024
However, Melanotan does not directly treat underlying skin problems or improve texture